No connection

Search Results

BWAY vs KMDA

BWAY
BrainsWay Ltd.
NEUTRAL
Price
$12.26
Market Cap
$490.8M
Sector
Healthcare
AI Confidence
60%
KMDA
Kamada Ltd.
NEUTRAL
Price
$8.49
Market Cap
$490.9M
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
BWAY
68.11
KMDA
24.26
Forward P/E
BWAY
27.45
KMDA
14.31
P/B Ratio
BWAY
6.14
KMDA
1.82
P/S Ratio
BWAY
9.4
KMDA
2.72
EV/EBITDA
BWAY
68.3
KMDA
10.78

Profitability

Gross Margin
BWAY
75.42%
KMDA
42.34%
Operating Margin
BWAY
13.17%
KMDA
7.95%
Profit Margin
BWAY
14.62%
KMDA
11.19%
ROE
BWAY
11.26%
KMDA
7.64%
ROA
BWAY
2.61%
KMDA
4.37%

Growth

Revenue Growth
BWAY
27.4%
KMDA
14.5%
Earnings Growth
BWAY
390.8%
KMDA
-14.1%

Financial Health

Debt/Equity
BWAY
0.09
KMDA
0.04
Current Ratio
BWAY
3.83
KMDA
4.07
Quick Ratio
BWAY
3.24
KMDA
2.2

Dividends

Dividend Yield
BWAY
--
KMDA
2.94%
Payout Ratio
BWAY
0.0%
KMDA
0.0%

AI Verdict

BWAY NEUTRAL

BWAY shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 8/9). Key strengths include strong valuation and growth metrics. Price trades at a 130.9% premium to fair value estimate ($5.31), limiting near-term upside from a valuation perspective.

Strengths
Strong financial trend (Piotroski F-Score: 8/9)
Strong revenue growth of 27.4%
Low debt with D/E ratio of 0.09
Risks
High valuation with P/E of 68.1
Premium vs Graham Number ($2.84)
Price trades at a 130.9% premium to fair value estimate ($5.31), limiting near-term upside from a valuation perspective.
KMDA NEUTRAL

KMDA presents a dichotomy between a fortress-like balance sheet and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health and the Debt/Equity ratio (0.04) is exceptionally low, the stock trades at a significant premium to its Graham Number ($6.06) and Intrinsic Value ($2.45). The attractive PEG ratio (0.63) suggests growth is undervalued, but this is offset by negative YoY earnings growth (-14.10%) and a bearish technical trend.

Strengths
Exceptional liquidity with a Current Ratio of 4.07
Negligible leverage with Debt/Equity at 0.04
Strong PEG ratio (0.63) indicating potential growth undervaluation
Risks
Significant disconnect between current price ($8.49) and Intrinsic Value ($2.45)
Negative earnings growth (-14.10% YoY) despite revenue gains
Bearish technical trend (0/100 score)

Compare Another Pair

BWAY vs KMDA: Head-to-Head Comparison

This page compares BrainsWay Ltd. (BWAY) and Kamada Ltd. (KMDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile